Company Name: GW Pharmaceuticals Plc
GW Pharmaceuticals Plc is a biopharmaceutical company. The company is engaged in the development/commercialization of cannabinoid medicines using its proprietary cannabinoid product platform. The company’s Sativex is approved in over 20 countries as a treatment for multiple sclerosis spasticity.
Ticker Symbol: GWPH (NASDAQ)
Company Website: www.gwpharm.com
Social Media: GW Pharmaceuticals LinkedIn
Headquarters: Cambridge, UK